Significant Ownership of Sands Capital Alternatives, LLC

Signature - Title
/s/ Jonathan Goodman - Jonathan Goodman, General Counsel
Location
Arlington, VA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Sands Capital Alternatives, LLC.

Notify me when Sands Capital Alternatives, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Sands Capital Alternatives, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ABOS Acumen Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 5.6% $3,861,295 3,417,075 Sands Capital Alternatives, LLC 30 Jun 2025
KVYO Klaviyo, Inc. Series A Common Stock, par value $0.001 per share 4.9% $127,806,680 4,416,264 SANDS FRANK M. 31 Mar 2025

Schedules 13D/G Reported by Sands Capital Alternatives, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.